About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Malignant Hematology
Nonmalignant Hematology
Updates in Oncology
Topics in Cancer
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
A
Novel Treatment Options for AL & ATTR Amyloidosis
By
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
FEATURING
Anuj Mahindra
By
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
FEATURING
Anuj Mahindra
153 views
September 4, 2019
1 Comment
Login to view comments.
Click here to Login
Malignant Hematology
13:11
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Waldenstrom's Macroglobulinemia - Novel Agents in Initial Treat…
Feat.
A. Mahindra
26:26
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Novel Treatment Options for AL & ATTR Amyloidosis
Feat.
A. Mahindra
17:11
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
First Line Treatment for CLL - Ibrutinib Plus Obinutuzumab, Ibrutini…
Feat.
W. Wierda
13:01
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Future Standard of Care Regimens in CLL: Ibrutinib + Venetoclax Comb…
Feat.
W. Wierda
09:20
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Treatment for Relapsed/Refractory CLL - Updates from MURANO Trial (V…
Feat.
W. Wierda
10:01
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Primary CNS Lymphoma - Clinical Features & Staging, Pretreatment…
Feat.
C. Grommes
13:27
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Treatment of Primary CNS Lymphoma: Upfront Regimen, Surgery, Treatme…
Feat.
C. Grommes
13:57
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Targeted Therapies in CNS Lymphoma & Salvage Options per NCCN Gu…
Feat.
C. Grommes
09:16
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
AML and CD33 Targeted Therapy - Results from Gemtuzumab Ozogamicin T…
Feat.
A. Perl
08:56
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Novel Treatment Options for High-Risk/Eldery AML Patients: CPX-351, …
Feat.
A. Perl
18:23
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Targeting FLT3 mutations in AML: Daunorubicin, Midostaurin, Sorafeni…
Feat.
A. Perl
06:37
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Targeting IDH Inhibitors in AML with Enasidenib and Ivosidenib
Feat.
A. Perl
32:01
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Frontline Treatment Options for Hodgkin's Lymphoma: Response-Ad…
Feat.
J. Svoboda
15:22
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Relapsed/Refractory Hodgkin Lymphoma - Salvage Treatments, Nivolumab…
Feat.
J. Svoboda
22:03
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Frontline Strategy for Aggressive Lymphoma - Can we Replace RCHOP?
Feat.
J. Westin
23:24
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Treatment of Relapsed Aggressive Lymphoma - Evaluating CAR T Trials
Feat.
J. Westin
09:49
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Overview of Diagnosis and Prognosis in Pediatric vs. Adult ALL
Feat.
H. Kantarjian
16:17
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Pediatric Inspired Regimens in Adult ALL: Is Combination Therapy Bet…
Feat.
H. Kantarjian
21:08
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
MRD-Positive ALL Treatment Options in 2019: Antibody Cocktail Regime…
Feat.
H. Kantarjian